A. West

发表

New and emerging HDAC inhibitors for cancer treatment.

R. Johnstone, A. West, 2014, The Journal of clinical investigation.

Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1.

A. Bert, P. Cockerill, A. West, 2010, Leukemia research.

Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies

R. Johnstone, M. Smyth, A. West, 2011, Proceedings of the National Academy of Sciences.

Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

R. Johnstone, M. Smyth, H. Duret, 2012, Cancer research.

The anticancer effects of HDAC inhibitors require the immune system

R. Johnstone, M. Smyth, A. West, 2014, Oncoimmunology.

Therapeutics , Targets , and Chemical Biology An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors

R. Johnstone, M. Smyth, L. Cluse, 2013 .

An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.

R. Johnstone, M. Smyth, L. Cluse, 2013, Cancer research.

Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism.

B. Jenkins, M. Oshima, C. Gabay, 2018, Cancer research.

Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema

S. Rose-John, B. Jenkins, P. King, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Blockade of the protease ADAM17 ameliorates experimental pancreatitis

Linden J. Gearing, S. Rose-John, B. Jenkins, 2022, Proceedings of the National Academy of Sciences of the United States of America.

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.

S. Lowe, P. L. Bergsagel, J. Zuber, 2012, Blood.

oncogene-driven mouse B cell lymphoma myc NKT cell adjuvant-based tumor vaccine for treatment of

P. L. Bergsagel, J. Zuber, R. Johnstone, 2012 .

Inflammatory and non-inflammatory roles for Toll-like receptors in gastrointestinal cancer.

B. Jenkins, A. West, 2015, Current pharmaceutical design.

Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation

B. Jenkins, M. Oshima, H. Oshima, 2022, Cellular and molecular gastroenterology and hepatology.

The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects

R. Johnstone, M. Smyth, A. West, 2012, Oncoimmunology.

Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer

J. Dickinson, A. Polanowski, J. Chuckowree, 2015, The Prostate.

Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer

B. Jenkins, A. West, S. Bozinovski, 2021, Oncogene.

The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1

J. Dickinson, Phillippa C. Taberlay, A. West, 2016, Journal of cellular biochemistry.

STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis

Linden J. Gearing, B. Jenkins, M. Oshima, 2021, Gut.

TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma

Linden J. Gearing, M. Pajic, P. Hertzog, 2021, Oncogene.

Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition Receptor

Linden J. Gearing, B. Jenkins, A. West, 2022, Frontiers in Oncology.

Constitutive STAT3 serine phosphorylation promotes Helicobacter-mediated gastric disease.

B. Jenkins, A. West, D. Gough, 2020, The American journal of pathology.

Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.

J. Flynn, M. Smyth, P. Darcy, 2012, Cancer research.

Serine-phosphorylated STAT3 promotes tumorigenesis via modulation of RNA polymerase transcriptional activity.

B. Jenkins, A. West, D. Gough, 2019, Cancer research.

Hyperactive gp130/STAT3‐driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development

B. Jenkins, M. Oshima, H. Oshima, 2018, International journal of cancer.

Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2

P. Tan, B. Jenkins, N. Deng, 2019, International journal of cancer.

The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock

R. Johnstone, B. Martin, J. Shortt, 2016, Oncogenesis.

The cytosolic DNA sensor AIM2 promotes Helicobacter‐induced gastric pathology via the inflammasome

B. Jenkins, C. Gabay, A. West, 2023, Immunology and cell biology.

Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection

M. Tate, A. Gearing, A. West, 2023, Clinical & translational immunology.

Investigating the Role of Toll-Like Receptors in Mouse Models of Gastric Cancer.

B. Jenkins, A. West, 2016, Methods in molecular biology.

Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer

T. Ushijima, L. Yu, B. Jenkins, 2017, Oncogene.

Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

R. Johnstone, M. Smyth, H. Yagita, 2012, Cancer research.